PPARGC1A and neoplasm: Together, our study provides a molecular basis for CRAT as a critical tumor suppressor in OC progression by enhancing PGC-1α-mediated mitochondrial biogenesis and metabolism, highlighting CRAT as a promising prognostic marker and therapeutic target in the treatment of OC.